Eduardo Mancilla-Rivera

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Functional crosstalk between the vanilloid and endocannabinoid systems in modulating vascular tone: implications for (neuro)vascular disorder therapy.

Functional crosstalk between the vanilloid and endocannabinoid systems in modulating vascular tone: implications for (neuro)vascular disorder therapy.

Journal: The journal of headache and pain

Published: March 28, 2025

Sex difference in TRPM3 channel functioning in nociceptive and vascular systems: an emerging target for migraine therapy in females?

Sex difference in TRPM3 channel functioning in nociceptive and vascular systems: an emerging target for migraine therapy in females?

Journal: The journal of headache and pain

Published: December 20, 2024

Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders.

Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders.

Journal: British journal of pharmacology

Published: June 18, 2024

Functional Analysis of TRPA1, TRPM3, and TRPV1 Channels in Human Dermal Arteries and Their Role in Vascular Modulation.

Functional Analysis of TRPA1, TRPM3, and TRPV1 Channels in Human Dermal Arteries and Their Role in Vascular Modulation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 22, 2023

Intracellular pathways of calcitonin gene-related peptide-induced relaxation of human coronary arteries: A key role for Gβγ subunit instead of cAMP.

Intracellular pathways of calcitonin gene-related peptide-induced relaxation of human coronary arteries: A key role for Gβγ subunit instead of cAMP.

Journal: British journal of pharmacology

Published: November 15, 2023

Prolactin and oxytocin: potential targets for migraine treatment.

Prolactin and oxytocin: potential targets for migraine treatment.

Journal: The journal of headache and pain

Published: December 30, 2022

Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.

Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.

Journal: The journal of headache and pain

Published: January 05, 2022

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus.

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus.

Journal: Frontiers in neurology

Published: March 26, 2021

CGRP inhibitors for migraine prophylaxis: a safety review.

CGRP inhibitors for migraine prophylaxis: a safety review.

Journal: Expert opinion on drug safety

Published: August 20, 2020

Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats.

Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats.

Journal: British journal of pharmacology

Published: October 27, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026